Proteomic profiling of baseline CSF and serum from HDClarity identifies signatures for Huntington disease staging and stratification
Background Sensitive biomarkers that objectively stage Huntington disease (HD) are needed to improve participant stratification and facilitate the enrichment of clinical trials with biologically and clinically homogeneous populations. The HDClarity study, an international longitudinal biofluid collection initiative for...